This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borenshtein, D.
Right arrow Articles by Schauer, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borenshtein, D.
Right arrow Articles by Schauer, D. B.

 Previous Article  |  Next Article 

Infection and Immunity, July 2007, p. 3271-3281, Vol. 75, No. 7
0019-9567/07/$08.00+0     doi:10.1128/IAI.01810-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Development of Fatal Colitis in FVB Mice Infected with Citrobacter rodentium{triangledown}

Diana Borenshtein,1 Prashant R. Nambiar,2 Elizabeth B. Groff,1,2 James G. Fox,1,2 and David B. Schauer1,2*

Biological Engineering Division,1 Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts2

Received 14 November 2006/ Returned for modification 3 January 2007/ Accepted 18 April 2007

Citrobacter rodentium is the causative agent of transmissible murine colonic hyperplasia. The disease is characterized by severe but temporary epithelial hyperplasia with limited inflammation in the descending colon of adult mice on a variety of genetic backgrounds. The natural history of infection with this murine pathogen has been characterized in outbred Swiss Webster (SW) mice but not in the cognate inbred FVB strain. In contrast to subclinical infection in SW mice, 12-week-old FVB mice developed overt disease with significant weight loss and mortality beginning by 9 days postinoculation (dpi). By 21 dpi, more than 75% of infected FVB mice died or had to be euthanized, whereas no mortality developed in SW mice. Mortality in FVB mice was fully prevented by fluid therapy. Fecal shedding of bacteria was similar in both groups through 9 dpi; however, a slight but significant delay in bacterial clearance was observed in FVB mice by 12 to 18 dpi. SW mice developed hyperplasia with minimal inflammation in the descending colon. FVB mice developed epithelial cell hyperproliferation, severe inflammation with erosions and ulcers, and epithelial atypia by 6 dpi in the descending colon. In the majority of surviving FVB mice, colonic lesions, including epithelial atypia, were reversible, although a small percentage (5 to 7%) exhibited chronic colitis through 7 months postinoculation. The existence of susceptible and resistant lines of mice with similar genetic backgrounds will facilitate the identification of host factors responsible for the outcome of infection and may lead to the development of novel strategies for preventing and treating infectious colitis.


* Corresponding author. Mailing address: Biological Engineering Division, Room 56-787B, Massachusetts Institute of Technology, Cambridge, MA 02139. Phone: (617) 253-8113. Fax: (617) 258-0225. E-mail: schauer{at}mit.edu

{triangledown} Published ahead of print on 30 April 2007.

Editor: J. B. Bliska


Infection and Immunity, July 2007, p. 3271-3281, Vol. 75, No. 7
0019-9567/07/$08.00+0     doi:10.1128/IAI.01810-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • McBee, M. E., Zheng, P. Z., Rogers, A. B., Fox, J. G., Schauer, D. B. (2008). Modulation of Acute Diarrheal Illness by Persistent Bacterial Infection. Infect. Immun. 76: 4851-4858 [Abstract] [Full Text]